mk 0591 has been researched along with Bronchial Hyperreactivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bel, EH; De Smet, M; Depré, M; Diamant, Z; Friedman, BS; Hilliard, D; Sterk, PJ; Timmers, MC; van der Veen, H | 1 |
| Black, C; Ellis, R; Ford-Hutchinson, A; Lane, CG; O'Byrne, PM; Stevens, WH; Tagari, P; Woolley, MJ | 1 |
1 trial(s) available for mk 0591 and Bronchial Hyperreactivity
| Article | Year |
|---|---|
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
Topics: 5-Lipoxygenase-Activating Proteins; Administration, Oral; Adult; Allergens; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Carrier Proteins; Creatinine; Double-Blind Method; Forced Expiratory Volume; Histamine; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Male; Membrane Proteins; Quinolines; Time Factors | 1995 |
1 other study(ies) available for mk 0591 and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Effect of FLAP antagonist MK-0591 on leukotriene production and ozone-induced airway responses in dogs.
Topics: 5-Lipoxygenase-Activating Proteins; Acetylcholine; Airway Resistance; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Carrier Proteins; Dogs; Indoles; Inflammation; Leukotriene Antagonists; Leukotriene B4; Leukotriene E4; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Ozone; Quinolines; Respiratory System | 1994 |